CB
Charles Bancroft BOARD MEMBER
Insider track record Other Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Charles Bancroft. Director active across 1 company, notably GSK plc. In total, 27 reports have been recorded. History available since 20 June 2023. The latest transaction was disclosed on 22 June 2026 (Purchase). Regulator: RNS (LSE). The full history is free.
Declarations 27 total
● Senior Independent Non-Executive Director · Executives · 22 Jun 2026 · GSK plc 1,855 shares @ £50.6908 0.0001% mcap 84.1% of flow US37733W2044⌘ RNS:9632737-2 Ideal exit: 19 Mar 2027 (T+270) ● Senior Independent Non-Executive Director · Executives · 22 Jun 2026 · GSK plc 1,855 shares @ £0.5069 0.0000% mcap 5.3% of flow US37733W2044⌘ RNS:1cabaef6-2e05-4f58-a412-24a2f7509642-2 Ideal exit: 19 Mar 2027 (T+270) ● Senior Independent Non-Executive Director · Executives · 9 Apr 2026 · GSK plc 313 shares @ £0.5893 0.0000% mcap 1.1% of flow US37733W2044⌘ RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-11 Ideal exit: 4 Jan 2027 (T+270) ● Senior Independent Non-Executive Director · Executives · 20 Mar 2026 · GSK plc 1,536 shares @ £0.5179 0.0000% mcap 4.8% of flow US37733W2044⌘ RNS:c2055913-103f-4927-b6f8-8f0835af9e8e-3 Ideal exit: 15 Dec 2026 (T+270) ● Senior Independent Non-Executive Director · Executives · 9 Jan 2026 · GSK plc 316 shares @ £0.5043 1.0% of flow US37733W2044⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-35 Ideal exit: 6 Oct 2026 (T+270) ● Senior Independent Non-Executive Director · Executives · 19 Dec 2025 · GSK plc 1,577 shares @ £0.4855 4.6% of flow US37733W2044⌘ RNS:5a98a0c7-d756-450b-83e9-f26937fe1a0f-2 Ideal exit: 15 Sept 2026 (T+270) ● Senior Independent Non-Executive Director · Executives · 10 Oct 2025 · GSK plc 340 shares @ £0.4374 1.0% of flow US37733W2044⌘ RNS:5859068-26 Ideal exit: 7 Jul 2026 (T+270) ● Senior Independent Non-Executive Director · Executives · 19 Sept 2025 · GSK plc 1,880 shares @ £0.4074 5.1% of flow US37733W2044⌘ RNS:5830475-2 Ideal exit: 16 Jun 2026 (T+270) ● Senior Independent Non-Executive Director · Executives · 11 Jul 2025 · GSK plc 364 shares @ £0.3854 0.9% of flow US37733W2044⌘ RNS:5737340-33 Ideal exit: 7 Apr 2026 (T+270) ● Senior Independent Non-Executive Director · Executives · 20 Jun 2025 · GSK plc 2,021 shares @ £0.379 5.6% of flow US37733W2044⌘ RNS:5708028-3 Ideal exit: 17 Mar 2026 (T+270) ● Senior Independent Non-Executive Director · Executives · 20 Jun 2025 · GSK plc 2,021 shares @ £0.379 5.6% of flow US37733W2044⌘ RNS:5707630-3 Ideal exit: 17 Mar 2026 (T+270) ● Senior Independent Non-Executive Director · Executives · 11 Apr 2025 · GSK plc 174 shares @ £0.3412 0.4% of flow US37733W2044⌘ RNS:5617047-1 Ideal exit: 6 Jan 2026 (T+270) ● Senior Independent Non-Executive Director · Executives · 25 Mar 2025 · GSK plc 15,843 shares @ £0.3881 46.1% of flow US37733W2044⌘ RNS:5593269-0 ● Senior Independent Non-Executive Director · Executives · 20 Mar 2025 · GSK plc 1,969 shares @ £0.3927 13.6% of flow US37733W2044⌘ RNS:5584787-3 Ideal exit: 15 Dec 2025 (T+270) ● Senior Independent Non-Executive Director · Executives · 10 Jan 2025 · GSK plc 139 shares @ £0.3335 0.8% of flow US37733W2044⌘ RNS:5498728-17 Ideal exit: 7 Oct 2025 (T+270) ● Senior Independent Non-Executive Director · Executives · 20 Dec 2024 · GSK plc 2,184 shares @ £0.3381 13.2% of flow US37733W2044⌘ RNS:5479029-3 Ideal exit: 16 Sept 2025 (T+270) ● Senior Independent Non-Executive Director · Executives · 11 Oct 2024 · GSK plc 105 shares @ £0.3906 1.0% of flow US37733W2044⌘ RNS:5388451-1 Ideal exit: 8 Jul 2025 (T+270) ● Senior Independent Non-Executive Director · Executives · 23 Sept 2024 · GSK plc 1,801 shares @ £0.4101 18.2% of flow US37733W2044⌘ RNS:5362280-2 Ideal exit: 20 Jun 2025 (T+270) ● Senior Independent Non-Executive Director · Executives · 12 Jul 2024 · GSK plc 84 shares @ £0.3933 1.0% of flow US37733W2044⌘ RNS:5266837-11 Ideal exit: 8 Apr 2025 (T+270) ● Senior Independent Non-Executive Director · Executives · 20 Jun 2024 · GSK plc 1,811 shares @ £0.4076 22.1% of flow US37733W2044⌘ RNS:5235239-2 Ideal exit: 17 Mar 2025 (T+270) ● Independent Non-Executive Director · Executives · 12 Apr 2024 · GSK plc 68 shares @ £0.4096 0.8% of flow US37733W2044⌘ RNS:5143847-25 Ideal exit: 7 Jan 2025 (T+270) ● Senior Independent Non-Executive Director · Executives · 20 Mar 2024 · GSK plc 1,653 shares @ £0.419 27.0% of flow US37733W2044⌘ RNS:5116598-3 Ideal exit: 15 Dec 2024 (T+270) ● Independent Non-Executive Director · Executives · 12 Jan 2024 · GSK plc 46 shares @ £0.4011 0.7% of flow US37733W2044⌘ RNS:5034561-24 Ideal exit: 8 Oct 2024 (T+270) ● Senior Independent Non-Executive Director · Executives · 20 Dec 2023 · GSK plc 1,757 shares @ £0.3662 34.3% of flow US37733W2044⌘ RNS:5012405-3 Ideal exit: 15 Sept 2024 (T+270) ● Independent Non-Executive Director · Executives · 13 Oct 2023 · GSK plc 32 shares @ £0.3691 0.6% of flow US37733W2044⌘ RNS:4939502-3 Ideal exit: 9 Jul 2024 (T+270) 25 of 27 declarations
Load more (2 remaining) About Charles Bancroft Charles Bancroft is a declarant who has made 27 filings in total. In his most recent filings, he has made purchases of shares in GSK plc, with a total purchase amount of 121447 EUR. Notable transactions include a purchase of 108343.02 EUR on June 24, 2026, as well as other purchases of varying amounts in March and June 2025 and 2026.